1. Low osmolar contrast media

   Newsletter Article 16 February 2013 Pages: 2 - 2

2. Mechanisms of adverse drug interactions

   Newsletter Article 16 February 2013 Pages: 2 - 3

3. Recognition and treatment of methyl alcohol poisoning

   Newsletter Article 16 February 2013 Pages: 3 - 3

4. Aciclovir: a safe drug?

   Newsletter Article 16 February 2013 Pages: 3 - 3

5. ACE inhibitors

   Newsletter Article 16 February 2013 Pages: 4 - 4

6. Amineptine overdose

   Newsletter Article 16 February 2013 Pages: 4 - 4

7. Amiodarone

   Newsletter Article 16 February 2013 Pages: 4 - 4

8. Amitriptyline overdose

   Newsletter Article 16 February 2013 Pages: 4 - 4

9. Amoxapine overdose

   Newsletter Article 16 February 2013 Pages: 4 - 4

10. Amphotericin B

    Newsletter Article 16 February 2013 Pages: 4 - 4

11. Anti-inflammatories, nonsteroidal

    Newsletter Article 16 February 2013 Pages: 4 - 5

12. Antineoplastics

    Newsletter Article 16 February 2013 Pages: 5 - 5

13. Aspirin

    Newsletter Article 16 February 2013 Pages: 5 - 5

14. Bleomycin

    Newsletter Article 16 February 2013 Pages: 5 - 5

15. Bleomycin see Cisplatin/vinblastine/bleomycin

    Newsletter Article 16 February 2013 Pages: 5 - 5

16. Captopril

    Newsletter Article 16 February 2013 Pages: 5 - 5

17. Cisplatin/vinblastine/bleomycin

    Newsletter Article 16 February 2013 Pages: 5 - 5

18. Cocaine abuse

    Newsletter Article 16 February 2013 Pages: 5 - 5

19. Cocaine overdose

    Newsletter Article 16 February 2013 Pages: 6 - 6

20. Corbadrine see Propranolol interaction

    Newsletter Article 16 February 2013 Pages: 6 - 6

21. Cyclosporin

    Newsletter Article 16 February 2013 Pages: 6 - 6

22. Cyclosporin interaction

    Newsletter Article 16 February 2013 Pages: 6 - 6

23. Doxorubicin

    Newsletter Article 16 February 2013 Pages: 6 - 6

24. Enalapril

    Newsletter Article 16 February 2013 Pages: 6 - 6

25. Etoposide

    Newsletter Article 16 February 2013 Pages: 6 - 7

26. Etretinate

    Newsletter Article 16 February 2013 Pages: 7 - 7

27. Ganciclovir

    Newsletter Article 16 February 2013 Pages: 7 - 8

28. Hydrochlorothiazide/triamterene

    Newsletter Article 16 February 2013 Pages: 8 - 8

29. Indomethacin see Sulindac/indomethacin

    Newsletter Article 16 February 2013 Pages: 8 - 8

30. Labetalol

    Newsletter Article 16 February 2013 Pages: 8 - 8

31. Lithium

    Newsletter Article 16 February 2013 Pages: 8 - 8

32. Maprotiline

    Newsletter Article 16 February 2013 Pages: 8 - 8

33. Marijuana

    Newsletter Article 16 February 2013 Pages: 8 - 8

34. Methamphetamine abuse

    Newsletter Article 16 February 2013 Pages: 8 - 8

35. Methyldopa

    Newsletter Article 16 February 2013 Pages: 8 - 8

36. Methysergide

    Newsletter Article 16 February 2013 Pages: 8 - 9

37. Nitroglycerin

    Newsletter Article 16 February 2013 Pages: 9 - 9

38. Papaverine

    Newsletter Article 16 February 2013 Pages: 9 - 9

39. Penicillamine

    Newsletter Article 16 February 2013 Pages: 9 - 9

40. Phenothiazines

    Newsletter Article 16 February 2013 Pages: 9 - 9

41. Plasminogen activator/streptokinase

    Newsletter Article 16 February 2013 Pages: 9 - 9

42. Plicamycin

    Newsletter Article 16 February 2013 Pages: 9 - 9

43. Propranolol

    Newsletter Article 16 February 2013 Pages: 9 - 9

44. Propranolol interaction

    Newsletter Article 16 February 2013 Pages: 10 - 10

45. Quinine overdose

    Newsletter Article 16 February 2013 Pages: 10 - 10

46. Scopolamine

    Newsletter Article 16 February 2013 Pages: 10 - 10

47. Sodium fluoride

    Newsletter Article 16 February 2013 Pages: 10 - 10

48. Sulfasalazine

    Newsletter Article 16 February 2013 Pages: 10 - 10

49. Sulindac/indomethacin

    Newsletter Article 16 February 2013 Pages: 10 - 11

50. Testosterone

    Newsletter Article 16 February 2013 Pages: 11 - 11